Nvidia shares weren't moving much in extended trading. But make no mistake, the chipmaker's earnings report was impressive.
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.